ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 745

Soft Drink Intake and Progression of Radiographic Knee Osteoarthritis: Data From the Osteoarthritis Initiative

Bing Lu1, Jeffrey Driban2, Tim McAlindon3 and Charles Eaton4, 1Rheumatology, Brigham and Women's Hospital, Boston, MA, 2Tufts Medical Center, MA, 3Tufts Medical Center, Boston, MA, 4Center for Primary Care and Prevention, Memorial Hospital of Rhode Island, Providence, RI

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research I: Epidemiology and Outcomes in Rheumatic Disease

Session Type: Abstract Submissions (ACR)

Soft Drink Intake and Progression of Radiographic Knee Osteoarthritis: Data from the Osteoarthritis Initiative

Background/Purpose : Soft drink consumption has been associated with weight gain and obesity which is a significant risk factor of osteoarthritis (OA), but its role in the progression of OA is unclear. We examine the prospective association of soft drink consumption with radiographic progression of OA.

Methods: In the Osteoarthritis Initiative (OAI), 2149 participants (3066 knees) with radiographic knee OA and having dietary data at baseline were followed up to 12, 24, 36 and 48 months. The frequency of soft drink (not including diet drinks) consumption was assessed with a Block Brief Food Frequency Questionnaire that was completed at baseline. To measure the OA progression, we used the change of a precise quantitative joint space width (JSW) in medial compartment over time between the adjacent bones of the knee based on plain radiographs.  The multivariate linear models for repeated measures were used to test the independent association between soft drink intake and the change in JSW over time, while adjusting for Body Mass Index (BMI) and baseline disease severity and potential confounding factors.

Results: In stratified analyses by gender, we observed a significant dose-response relationship between soft drink intake and adjusted mean changes of JSW in men (p trend<0.001) after controlling for BMI and potential confounding factors.  With increasing levels of soft drink intake, the mean changes in JSW were 0.29mm, 0.39mm, 0.36mm and 0.59mm respectively.  When we further stratified by BMI tertiles, stronger dose-response relationship was found (changes in JSW were 0.21mm, 0.38mm, 0.40mm, 0.75mm respectively) in the lowest BMI tertile (BMI<27.5 kg/m2). In men with BMI ≥27.5 kg/m2, only highest soft drink level (≥5 times/week) was associated with increased JSW compared to no use. By contrast in women, a significant association and dose-response relationship was only observed with the lowest BMI tertile (BMI<27.3 kg/m2, p trend <0.001).

Conclusion: Our results suggest that frequent consumption of soft drinks may be associated with increased OA progression in men.  Replication of these novel findings in other prospective studies demonstrating the reduction in soft drink consumption leads to delay in OA progression are needed to test this hypothesis.

Table. Adjusted mean (SE) changes of Joint Space Width (JSW) by soft drink intake*

BMI tertiles┼

Soft drinks,

times / week

Men

Women

N

DJSW, mm*

P value

P trend

N

DJSW, mm*

P value

P trend

Total**

None

202                

0.29(0.03)

Referent

485                 

0.34(0.02)

Referent

≤1

439

0.39(0.02)

0.012

537

0.37(0.02)

0.343

2-4

140

0.36(0.04)

0.191

145

0.40(0.04)

0.192

≥5

107

0.59(0.05)

<0.001

<0.001

94

0.34(0.05)

0.984

0.499

T1

None

62

0.21(0.06)

Referent

181

0.29(0.04)

Referent

≤1

166

0.38(0.04)

0.012

191

0.42(0.04)

0.007

2-4

38

0.40(0.08)

0.043

30

0.52(0.08)

0.009

≥5

29

0.75(0.09)

<0.001

<0.001

17

0.41(0.11)

0.319

<0.001

T2

None

62

0.30(0.06)

Referent

168

0.38(0.04)

Referent

≤1

140

0.43(0.04)

0.076

170

0.31(0.04)

0.170

2-4

51

0.33(0.07)

0.733

51

0.40(0.06)

0.743

≥5

39

0.49(0.08)

0.050

0.313

27

0.31(0.09)

0.465

0.713

T3

None

78

0.38(0.05)

Referent

136

0.36(0.04)

Referent

≤1

133

0.39(0.04)

0.789

176

0.40(0.04)

0.516

2-4

51

0.38(0.07)

0.923

64

0.34(0.06)

0.721

≥5

39

0.62(0.08)

0.007

0.022

50

0.35(0.07)

0.876

0.766

* Adjusted for age, race, education, marital status, household income, employment, follow-up time, depression, knee injury and knee surgery, smoking, milk intake, total energy intake, baseline K-L grade and JSW, weight change, the changes of rim distance and beam angle.

** Adjusted for BMI as well

┼ BMI tertiles: Man:  T1: <27.5, T2: 27.5-30.8, T3 30.9+;  Women: T1: <27.3, T2: 27.3-32.0, T3 32.1+



Disclosure:

B. Lu,
None;

J. Driban,
None;

T. McAlindon,
None;

C. Eaton,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/soft-drink-intake-and-progression-of-radiographic-knee-osteoarthritis-data-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology